SE9902936D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902936D0 SE9902936D0 SE9902936A SE9902936A SE9902936D0 SE 9902936 D0 SE9902936 D0 SE 9902936D0 SE 9902936 A SE9902936 A SE 9902936A SE 9902936 A SE9902936 A SE 9902936A SE 9902936 D0 SE9902936 D0 SE 9902936D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- phenylethoxy
- benzothiazol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902936A SE9902936D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
AU64601/00A AU6460100A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
PCT/GB2000/003112 WO2001012191A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a glucocorticoid |
ARP000104310A AR025340A1 (es) | 1999-08-18 | 2000-08-18 | Composiciones farmaceuticas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902936A SE9902936D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9902936D0 true SE9902936D0 (sv) | 1999-08-18 |
Family
ID=20416694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9902936A SE9902936D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR025340A1 (sv) |
AU (1) | AU6460100A (sv) |
SE (1) | SE9902936D0 (sv) |
WO (1) | WO2001012191A2 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7345060B2 (en) | 2003-11-21 | 2008-03-18 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
MX2010013477A (es) | 2008-06-18 | 2010-12-21 | Astrazeneca Ab | Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta2 para el tratamiento de trastornos respiratorios. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902936A patent/SE9902936D0/sv unknown
-
2000
- 2000-08-14 AU AU64601/00A patent/AU6460100A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003112 patent/WO2001012191A2/en active Application Filing
- 2000-08-18 AR ARP000104310A patent/AR025340A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001012191A2 (en) | 2001-02-22 |
WO2001012191A3 (en) | 2001-09-07 |
AU6460100A (en) | 2001-03-13 |
AR025340A1 (es) | 2002-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04000920A (es) | Derivados de aminoisoxazol activos como inhibidores de la cinasa. | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
CA2396561A1 (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
CA2381097A1 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
DE60228857D1 (de) | Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung | |
CA2098302A1 (en) | Medicaments | |
CA2392879A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
WO2001062737A3 (en) | Amino pyrazole derivatives useful for the treatment of obesity and other disorders | |
NO20034612L (no) | 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer | |
WO2001098290A3 (en) | Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
FI932390A (fi) | Nya hydroxiaminsyra- och N-hydroxiureaderivat samt deras anvaendning | |
BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
HUP0104410A2 (hu) | Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
SE9902935D0 (sv) | Pharmaceutical compositions | |
SE9902937D0 (sv) | Pharmaceutical compositions | |
SE9902936D0 (sv) | Pharmaceutical compositions | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
SE9903995D0 (sv) | New combination | |
SE9902938D0 (sv) | Pharmaceutical compositions | |
SE0001916D0 (sv) | Novel formulation | |
IT1291340B1 (it) | Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale |